Shame there is some salty ex holders trying to push their uneducated opinion on to new investors. Most people have enjoyed the run from 2.6c up to 7+ hardly ill informed it would appear.
"Successful study results would mean a key breakthrough for MGC Pharma in the treatment of aggressive brain cancers, one of its key target clinical research treatment areas – Oncology"
These guys have a lot of products that could be game changers, once in a lifetime stuff.
Now that the Options are in the money(exercise price 4.5c expiry August 31 2021) it is more likely they will be exercised which would put $3.8 mil into MXC bank account. Last I heard they had $1.4mil in the bank as well (3oth Sep 2020) This suggests no cash flow problem to me.
Good luck long term holders, this is a very exciting stock to be apart of!
